STLN NASDAQ
Starling Oncology, Inc.
1W: +3.4%
1M: -2.4%
YTD: +16.6%
$6.17
-0.03 (-0.48%)
Weekly Expected Move ±6.9%
$5
$6
$6
$7
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider+$0.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$616.9M
52W Range2.32-7.05
Volume790,868
Avg Volume1,634,976
Beta0.44
Dividend—
Analyst Ratings
Company Info
CEODaniel Virnich
Employees641
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date2026-08-04
Websitestarlingoncology.com
18000 Studebaker Road, Suite 800
Cerritos, CA 90703
US
Cerritos, CA 90703
US
About Starling Oncology, Inc.
Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across multiple markets with a focus on delivering high-quality, patient-centered care.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Hively Brad | S-Sale | 298,853 | $6.51 | 2026-08-21 |
| Chernett Jorey | P-Purchase | 12,000 | $6.54 | 2026-08-14 |
| Chernett Jorey | S-Sale | 100 | $9.00 | 2026-08-13 |